On The Line: Beware angry Quebec voters, and, rogue AIs

On The Line: Beware angry Quebec voters, and, rogue AIs

From The Line Podcast by Line Editor

June 9, 2026 · 56 min

About this episode

The episode discusses the intersection of politics, technology, and trust, featuring insights on Quebec voters and cancer immunotherapy advancements.

In this episode of On The Line, host Matt Gurney is joined by two guests for conversations about politics, technology, and trust. This episode of On The Line is brought to you by BioCanRX, a federally funded, not-for-profit Canadian research network that specializes in bringing Canadian cancer immunotherapy research from the lab all the way to patients in clinical trials in Canada. Can science help your immune system detect and destroy cancer? Immunotherapy is about assisting your immune system in identifying unhealthy cells –– especially cancer –– that have found a way to evade detection. One way researchers are doing this is through something called CAR T. They draw your blood, isolate one type of your immune cells –– T-Cells –– and use a virus to inject genetic instructions that cause them to grow new receptors designed specifically to bind with your particular cancer. When those cells are re-infused into your body, they hopefully will be able to find and destroy your cancer. The results are promising. In one of the 16 trials BioCanRx funds based on Canadian technology, CLIC-01, the median number of months remaining for patients with late-stage leukemia and lymphoma tripled…

People in this episode

Host: Matt Gurney

Guest: PJ Fournier

Topics covered

  • politics
  • technology
  • trust
  • cancer immunotherapy
  • AI
  • Quebec voters

Keywords

  • Quebec voters
  • rogue AIs
  • cancer immunotherapy
  • BioCanRX
  • CAR T
  • T-Cells
  • clinical trials

Sponsors

BioCanRX

Mentioned in this episode

Organizations: CLIC-01

Places: Canada, Quebec

More episodes of The Line Podcast

Explore listener stats, chart rankings, contacts and more on the The Line Podcast podcast page.